AZAM is an independent advisory firm for HealthTech, MedTech and biopharma companies facing a transaction: divestitures, acquisitions, fundraising, and the preparation that decides the outcome long before the first investor meeting.
Most founders and owners run one or two transactions in their working life. The people on the other side of the table run several a month. We close that gap. We prepare the file, we build the case the way an investment committee actually reads it, we identify and approach the right counterparties, and we run the process through to closing.
The practice is led by Amine Marouf. Seven and a half years at Kurma Partners as Principal, around 800 opportunities reviewed a year and seed investments across Europe in diagnostics, monitoring and digital health. Then Investment Director, VC HealthTech, at BNP Paribas Developpement. He sits on Bpifrance juries under the France 2030 programme and is an expert for EIT Health. That is the point: your file is built by someone who spent seven years assessing files like it from the investors chair.
AZAM works directly and alongside Scale4Health, KingsRock and Tesuji, on mandates in France, EU, UK and US
AZAM also operates Spinova Ventures, which turns dormant R&D inside mid-market industrial companies into independent, investable spin-outs.
If you are preparing a sale, an acquisition or a round, the most useful conversation is the one before you start.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2025
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was AZAM founded?
AZAM was founded in 2025.
What industry is AZAM in?
AZAM operates in Business Consulting and Services. Find similar Business Consulting and Services investors on gritt.io.
Find investors for your startup like AZAM
Gritt sends AI-personalised outreach to each investor — from your Gmail
